1. Report Overview
1.1 Introduction to Gene Therapy R&D Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)

2 Executive Summary
2.1 Gene Therapy Has Experienced a Renaissance in Last 5 Years

3 Market Dynamics
3.1 Drivers
3.1.1 Robust Gene Therapy Pipeline to Boost Growth
3.1.2 Technological Advancements to Fuel Market Growth
3.1.3 Increasing Investments by Major Players
3.1.4 Growing Prevalence of Targeted Diseases Treatment
3.2 Restraints/Challenges
3.2.1 Cell & Gene Therapies Target Specific Diseases
3.2.2 High Cost to Stifle Gene Therapy R&D Growth Through 2031
3.2.3 Regulatory Scenarios to Challenge Industry Growth
3.3 Opportunities
3.3.1 Growing Number of Clinical Trials to Offer Lucrative Growth Opportunities
3.3.2 Facility Expansion Anticipated to Offer Lucrative Growth Prospects
3.4 Industry analysis - Porter's
3.4.1 Buyer Power
3.4.2 Supplier Power
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitute
3.4.5 Threat of New Entrants
3.5 Industry analysis - PEST Analysis
3.5.1 Political Factors Impacting Gene Therapy R&D Market
3.5.2 Economic Factors Impacting Gene Therapy R&D Market
3.5.3 Social Factors Impacting Gene Therapy R&D Market
3.5.4 Technological Factors Impacting Gene Therapy R&D Market

4 Gene Therapy R&D Market by Disease
4.1 Cancer Segment Market Forecast, 2021-2031
4.1.1 Gene Therapy Interventions Have the Potential to Correct Molecular Defects That Contribute to Cancer Progression
4.1.2 Gene Therapy R&D Forecast for Cancer Segment, Recovery Scenarios (V, U, W, L)
4.2 Rare Diseases Sub-Segment Market Forecast, 2021-2031
4.2.1 Economic Burden of Rare Diseases to Fuel Segmental Growth
4.2.2 Gene Therapy R&D Forecast for Rare Diseases Segment, Recovery Scenarios (V, U, W, L)
4.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
4.3.1 Rising CVDs Patient Pool to Augur Segmental Growth
4.3.2 Gene Therapy R&D Forecast for CVDs Segment, Recovery Scenarios (V, U, W, L)
4.4 Ophthalmic Diseases Segment Market Forecast, 2021-2031
4.4.1 Gene Therapy Making Progress in Ophthalmology
4.4.2 Gene Therapy R&D Forecast for Ophthalmic Diseases Segment, Recovery Scenarios (V, U, W, L)
4.5 Hematology Segment Market Forecast, 2021-2031
4.5.1 Growing Burden of Blood Related Disorders to Boost Segment Growth
4.5.2 Selected Gene Therapy Amenable Hematological Disorders
4.5.3 Companies Developing Gene Therapies for Hematological Disorders
4.5.4 Gene Therapy R&D Forecast for Hematology Segment, Recovery Scenarios (V, U, W, L)
4.6 Neurological Segment Market Forecast, 2021-2031
4.6.1 Adeno-associated viral (AAV) vectors are a rapidly emerging gene therapy platform for the treatment of neurological diseases
4.6.2 Gene Therapy R&D Forecast for Neurological Segment, Recovery Scenarios (V, U, W, L)
4.7 Diabetes Mellitus Segment Market Forecast, 2021-2031
4.7.1 Gene Therapy R&D Forecast for Diabetes Mellitus Segment, Recovery Scenarios (V, U, W, L)
4.8 Other Diseases Segment Market Forecast, 2021-2031
4.8.1 Gene Therapy R&D Forecast for Others Segment, Recovery Scenarios (V, U, W, L)

5 Gene Therapy R&D Market by Vector
5.1 Viral Sub-Segment Market Forecast, 2021-2031
5.1.1 Facility Expansion by Major Players to Fuel Viral Sub-Segment Industry Growth
5.1.2 Retrovirus
5.1.3 Adenovirus
5.1.4 AAV (Adeno-Associated Virus)
5.1.5 Lentivirus
5.1.6 Others
5.1.7 Gene Therapy R&D Forecast for Viral Segment, Recovery Scenarios (V, U, W, L)
5.2 Non-Viral Sub-Segment Market Forecast, 2021-2031
5.2.1 Growing Research Focus on Developing Optimal Delivery Method to Fuel Sub-Segment Growth
5.2.2 Naked DNA
5.2.3 Gene-Gun
5.2.4 Electroporation
5.2.5 Gene Therapy R&D Forecast for Non-Viral Segment, Recovery Scenarios (V, U, W, L)

6 Gene Therapy R&D Market by Techniques
6.1 Gene Augmentation Therapy Segment Market Forecast, 2021-2031
6.1.1 Gene Therapy R&D Forecast for Gene Augmentation Segment, Recovery Scenarios (V, U, W, L)
6.2 Gene Replacement Therapy Segment Market Forecast, 2021-2031
6.2.1 Gene Therapy R&D Forecast for Gene Replacement Segment, Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Gene Therapy R&D Market Forecasts 2021-2031
7.1 Global Gene Therapy R&D Market by Region Forecast 2021-2031
7.2 Recovery Scenarios (V, U, W, L): Gene Therapy R&D Market Forecast by Region, 2021-2031

8 North America Gene Therapy R&D Market
8.1 North America Currently Dominates the Global Gene Therapy R&D Market
8.2 North America Gene Therapy R&D Market by Country, Forecast 2021-2031
8.3 North America Gene Therapy R&D Market Forecast by Disease
8.3.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Disease, 2021-2031
8.4 North America Gene Therapy R&D Market Forecast by Vector
8.4.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Vector, 2021-2031
8.5 North America Gene Therapy R&D Market Forecast by Techniques
8.5.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
8.6 U.S. Gene Therapy R&D Market Forecast, 2021-2031
8.6.1 U.S. Currently Dominating the North American Gene Therapy R&D Market
8.6.2 Increasing Prevalence of Genetic Disorders Anticipated to Fuel Regional Growth
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Gene Therapy R&D Market Forecast, 2021-2031
8.7 Canada Gene Therapy R&D Market Forecast, 2021-2031
8.7.1 Significant Growth Opportunities Due to Increasing Cancer Burden
8.7.2 Growing Geriatric Population to Fuel Demand for Gene Therapy R&D Through 2031
8.7.3 Recovery Scenarios (V, U, W, L): Canada Gene Therapy R&D Market Forecast, 2021-2031

9 Europe Gene Therapy R&D Market
9.1 Second Largest Gene Therapy R&D Industry Worldwide
9.2 Europe Gene Therapy R&D Market by Country, Forecast 2021-2031
9.3 Europe Gene Therapy R&D Market Forecast by Disease
9.3.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031
9.4 Europe Gene Therapy R&D Market Forecast by Vector
9.4.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031
9.5 Europe Gene Therapy R&D Market Forecast by Techniques
9.5.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031
9.6 Germany Gene Therapy R&D Market Forecast, 2021-2031
9.6.1 Germany Currently Dominates the European Gene Therapy R&D Market
9.6.2 Rising Geriatric Patient Pool to Offer Lucrative Growth Prospects
9.6.3 Increasing in New Pipeline Developments for Gene Therapy to Boost German Gene Therapy R&D Market
9.6.4 Recovery Scenarios (V, U, W, L): Germany Gene Therapy R&D Market Forecast, 2021-2031
9.7 UK Gene Therapy R&D Market Forecast, 2021-2031
9.7.1 Rising Number of Clinical Trials to Boost UK Gene Therapy R&D Market Growth
9.7.2 Rising Cancer Burden to Boost Regional Growth Over the Forecast Period
9.7.3 Growing Burden of Genetic Disorders to Fuel Regional Growth Through 2031
9.7.4 Recovery Scenarios (V, U, W, L): UK Gene Therapy R&D Market Forecast, 2021-2031
9.8 France Gene Therapy R&D Market Forecast, 2021-2031
9.8.1 Increasing Incidence of Genetic Disorders to Fuel French Gene Therapy R&D Market Growth
9.8.2 Rising Cancer Incidence to Fuel Gene Therapy R&D Growth
9.8.3 Presence of Major Biotech Firms Across France to Offer Lucrative Growth Prospects
9.8.4 Recovery Scenarios (V, U, W, L): France Gene Therapy R&D Market Forecast, 2021-2031
9.9 Italy Gene Therapy R&D Market Forecast, 2021-2031
9.9.1 Italian Gene Therapy R&D Market to Surge Owing to Rising Healthcare Expenditure
9.9.2 Italian Gene Therapy R&D Set to Witness Tremendous Growth
9.9.3 Recovery Scenarios (V, U, W, L): Italy Gene Therapy R&D Market Forecast, 2021-2031
9.10 Spain Gene Therapy R&D Market Forecast, 2021-2031
9.10.1 Rising Cancer Burden to Fuel Spanish Gene Therapy R&D Industry Growth
9.10.2 Recovery Scenarios (V, U, W, L): Spain Gene Therapy R&D Market Forecast, 2021-2031
9.11 Russia Gene Therapy R&D Market Forecast, 2021-2031
9.11.1 Rising Cancer Incidence to Fuel Russian Gene Therapy R&D Market Growth
9.11.2 Government Focus to Establish Special Fund for Gene Therapy to Fuel Regional Growth
9.11.3 Recovery Scenarios (V, U, W, L): Russia Gene Therapy R&D Market Forecast, 2021-2031
9.12 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031
9.12.1 Finland Gene Therapy R&D Another Promising Market in Rest of Europe
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031

10 Asia Pacific Gene Therapy R&D Market
10.1 Asia Pacific to Witness Highest Growth Rates Through 2031
10.2 Asia Pacific Gene Therapy R&D Market by Country, Forecast 2021-2031
10.3 Asia Pacific Gene Therapy R&D Market Forecast by Disease
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031
10.4 Asia Pacific Gene Therapy R&D Market Forecast by Vector
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031
10.5 Asia Pacific Gene Therapy R&D Market Forecast by Techniques
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031
10.6 Japan Gene Therapy R&D Market Forecast, 2021-2031
10.6.1 Japanese Gene Therapy R&D Market to Witness Highest CAGR Through 2031
10.6.2 Approval of Zolgensma by Japanese Government Anticipated to Boost Regional Growth
10.6.3 Ageing Japanese Population Anticipated to Offer Lucrative Growth Prospects Over the Next Decade
10.6.4 Recovery Scenarios (V, U, W, L): Japan Gene Therapy R&D Market Forecast, 2021-2031
10.7 China Gene Therapy R&D Market Forecast, 2021-2031
10.7.1 China Currently Accounts for Majority of the APAC Gene Therapy R&D Market Share
10.7.2 Strategic Collaboration to Fuel Chinese Gene Therapy R&D Market Over the Forecast Period
10.7.3 Recovery Scenarios (V, U, W, L): China Gene Therapy R&D Market Forecast, 2021-2031
10.8 India Gene Therapy R&D Market Forecast, 2021-2031
10.8.1 Burden of Genetic Disorders and Unmet Medical Needs to fuel Regional Gene Therapy R&D Industry Growth
10.8.2 India Continues to be a Key Player in Gene Therapy Related Research
10.8.3 Recovery Scenarios (V, U, W, L): India Gene Therapy R&D Market Forecast, 2021-2031
10.9 Australia Gene Therapy R&D Market Forecast, 2021-2031
10.9.1 Rising Chronic Disorders to Augur Australian Gene Therapy R&D Market Growth
10.9.2 Australia is Currently Undergoing Gene Therapy Clinical Trials to Treat a Variety of Genetic Health Conditions
10.9.3 Recovery Scenarios (V, U, W, L): Australia Gene Therapy R&D Market Forecast, 2021-2031
10.10 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031
10.10.1 SEA Economies Driving Rest of APAC Gene Therapy R&D Industry
10.10.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031

11 Latin America Gene Therapy R&D Market
11.1 Latin America Gene Therapy R&D Industry, One of the Emerging Regions Globally
11.1.1 Brazil First Among Latin American Economy to Approve Luxturna® and Zolgensma®
11.2 Latin America Gene Therapy R&D Market by Country, Forecast 2021-2031
11.3 Latin America Gene Therapy R&D Market Forecast by Disease
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031
11.4 Latin America Gene Therapy R&D Market Forecast by Vector
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031
11.5 Latin America Gene Therapy R&D Market Forecast by Techniques
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
11.6 Brazil Gene Therapy R&D Market Forecast, 2021-2031
11.6.1 Brazil Gene Therapy R&D Market to Witness Highest Growth Rate Across Latin American Region
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Gene Therapy R&D Market Forecast, 2021-2031
11.7 Mexico Gene Therapy R&D Market Forecast, 2021-2031
11.7.1 Mexican Gene Therapy R&D Currently Dominating the Latin American Region
11.7.2 Burgeoning Ant-Aging Research to Offer Lucrative Growth Prospects
11.7.3 Recovery Scenarios (V, U, W, L): Mexico Gene Therapy R&D Market Forecast, 2021-2031
11.8 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031
11.8.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031

12 Middle East and Africa Gene Therapy R&D Market
12.1 Growing Chronic Disease Patient Pool to Drive Demand for Gene Therapy R&D Industry Across MEA Region
12.2 Middle East and Africa Gene Therapy R&D Market by Country, Forecast 2021-2031
12.3 Middle East and Africa Gene Therapy R&D Market Forecast by Disease
12.3.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031
12.4 Middle East and Africa Gene Therapy R&D Market Forecast by Vector
12.4.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031
12.5 Middle East and Africa Gene Therapy R&D Market Forecast by Techniques
12.5.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031
12.6 GCC Gene Therapy R&D Market Forecast, 2021-2031
12.6.1 Rising Burden of Chronic Diseases to Fuel GCC Gene Therapy R&D Market Growth
12.6.2 Luxturna Approval in UAE Anticipated to Boost Gene Therapy R&D Market Over the Next Decade
12.6.3 Recovery Scenarios (V, U, W, L): GCC Gene Therapy R&D Market Forecast, 2021-2031
12.7 South Africa Gene Therapy R&D Market Forecast, 2021-2031
12.7.1 South Africa Currently Dominates the MEA Gene Therapy R&D Market
12.7.2 Investment in South African Gene Therapy R&D Industry to Boost Regional Growth
12.7.3 Recovery Scenarios (V, U, W, L): South Africa Gene Therapy R&D Market Forecast, 2021-2031
12.8 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031
12.8.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031

13 Competitive Landscape
13.1 Strategic Choices for Winning in Gene Therapy R&D Market
13.1.1 Diversification of Technical Risks
13.1.2 How to Achieve Long Term Benefits to Patients
13.1.3 Building Digital Capabilities
13.1.4 Mergers & Acquisitions to Offer Lucrative Growth Prospects for Players Across the Value Chain
13.2 Approved Cellular & Gene Therapy Products as of March 2021
13.3 Ongoing Gene Therapy Clinical Trials by Companies
13.4 Gene Therapy Companies Market Capitalization

14 Company Profiles
14.1 UniQure B. V.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis, 2015-2019
14.1.4 Pipeline: Gene Therapy
14.1.5 Recent Developments
14.2 Biogen
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis, 2015-2019
14.2.4 Product Benchmarking
14.2.5 Recent Developments
14.3 Bluebird Bio
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis, 2015-2019
14.3.4 Product Benchmarking
14.3.5 Recent Developments
14.4 Spark Therapeutics (Subsidiary of Roche)
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Recent Developments
14.5 Bayer
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis, 2015-2020
14.5.4 Product Benchmarking
14.5.5 Recent Developments
14.6 Pfizer, Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis, 2015-2020
14.6.4 Product Benchmarking
14.6.5 Recent Developments
14.7 Applied Genetic
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis, 2015-2020
14.7.4 Product Benchmarking
14.7.5 Recent Developments
14.8 Oxford Biomedica
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis, 2015-2019
14.8.4 Product Pipeline
14.8.5 Recent Developments
14.9 GenSight Biologics
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.10 Takeda Pharmaceuticals
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis, 2015-2020
14.10.4 Product Benchmarking
14.10.5 Recent Developments
14.11 Cellectis
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis, 2015-2019
14.11.4 Product Benchmarking
14.11.5 Recent Developments
14.12 Sangamo Therapeutics, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis, 2015-2019
14.12.4 Product Benchmarking
14.12.5 Recent Developments
14.13 REGENXBIO Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis, 2015-2019
14.13.4 Product Benchmarking
14.13.5 Recent Developments
14.14 Voyager Therapeutics
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis, 2015-2019
14.14.4 Product Benchmarking
14.14.5 Recent Developments
14.15 Bristol Myers Squibb
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis, 2015-2019
14.15.4 Product Benchmarking
14.15.5 Recent Developments
14.16 Benitec BioPharma
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis, 2015-2020
14.16.4 Product Benchmarking
14.17 F. Hoffmann-La Roche Ltd.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis, 2015-2019
14.17.4 Product Benchmarking
14.17.5 Recent Developments
14.18 Novartis Gene Therapies
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis, 2015-2020
14.18.4 Product Benchmarking
14.18.5 Recent Developments
14.19 Gilead Lifesciences, Inc.
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis, 2015-2019
14.19.4 Product Benchmarking
14.20 Sanofi
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Financial Analysis, 2015-2019
14.20.4 Product Benchmarking
14.20.5 Recent Developments
14.21 Transgene
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.22 Calimmune, Inc. (CSL Behiring)
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Product Benchmarking
14.22.4 Recent Developments
14.23 Astellas Pharma Inc.
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Financial Analysis, 2015-2020
14.23.4 Product Benchmarking
14.24 American Gene Technologies
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Product Benchmarking
14.25 Orchard Therapeutics
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Product Benchmarking
14.25.4 Recent Developments

15 Conclusion
15.2 Recommendations for Market Players
15.3 Leading Region & Highest CAGR Grossing Region Snapshot, 2021 & 2031

List of Tables
Table 1 Global Gene Therapy R&D Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 1 Promising Therapies in Development
Table 2 Gene, Cell & Tissue Bases Therapeutic Developers Financings by IPOs, 2020
Table 3 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Follow-Ons, 2020
Table 4 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Venture Capital, 2020
Table 5 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Partnership, 2020
Table 6 Global Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 7 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 8 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 9 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 10 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 11 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 12 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 13 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 14 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 15 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 16 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 17 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 18 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 19 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 20 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 21 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 22 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 23 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 24 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 25 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 26 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 27 Selected Gene Therapy Amenable Hematological Disorders
Table 28 Selected Gene Therapy Amenable Hematological Disorders
Table 29 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 30 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 31 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 32 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 33 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 34 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 35 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 36 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 37 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 38 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 39 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 41 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 42 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 43 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 44 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 46 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 47 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 48 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 49 Global Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 50 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 52 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 53 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 54 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 55 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 56 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 57 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 58 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 59 Global Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 60 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 61 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 62 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 63 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 64 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 65 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 66 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 67 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 68 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 69 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 70 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 71 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 72 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 73 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 74 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 75 North America Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 76 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 77 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 78 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 79 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 80 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 81 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 82 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 83 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 84 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 85 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 86 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 88 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 89 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 90 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 91 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 92 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 93 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 94 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 95 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 96 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 97 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 98 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 99 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 100 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 101 Europe Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 102 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 103 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 104 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 105 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 106 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 107 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 108 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'V' Shaped Recovery
Table 109 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'U' Shaped Recovery
Table 110 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'W' Shaped Recovery
Table 111 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): 'L' Shaped Recovery
Table 112 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)

Please contact our Customer Support Center to get the complete Table of Contents